Health Canada’s Explanatory notes for drug establishments on the preparation of a site master file (GUI-0005), published in April 2026, provides a comprehensive framework for manufacturers to document their quality management and production operations.
- Revised Heading Numbering: The most significant change in the 2026 version is a restructured numbering system. This was done to improve clarity and ensure the document mirrors the international PIC/S format exactly.
- Updated References: All internal and external links have been updated to point to the current versions of related guidance, such as the Good Manufacturing Practices Guide for Drug Products (GUI-0001) and international standards.
Clarification of “Living Document” Status
While the requirement for a Site Master File (SMF) to be a “living document” existed previously, the 2026 guidance places greater emphasis on version control.
- The Change: The update explicitly mandates that the SMF must be integrated into the manufacturer’s Quality Management System (QMS) with specific protocols for regular review cycles, rather than just being updated “as needed.”
Content Specifics (Alignment with Modern Practices)
The 2026 update provides more “prescriptive” language regarding the sections you mentioned:
- Quality Risk Management (QRM): There is now a more detailed expectation for how QRM methodologies are summarized within the SMF.
- Personnel Oversight: The requirement to demonstrate “adequate oversight” now specifically suggests including staffing levels relative to production volume to ensure quality isn’t compromised by understaffing.
- Digital Integration: The guidance now better accounts for electronic systems in the “Technical Descriptions” section, requiring manufacturers to briefly outline their validated electronic data management systems.
